Millennium Management’s Integra LifeSciences IART Stock Holding History

Millennium Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,000	Closed	-$335K	–	7144
2021 Q4	$335K	Buy	+5,000	New	+$338K	﹤0.01%	5427
2020 Q4	–	Sell	-10,000	Closed	-$472	–	5371
2020 Q3	$472	Buy	+10,000	New	+$476K	﹤0.01%	3610
2020 Q2	–	Sell	-5,000	Closed	-$223K	–	4349
2020 Q1	$223K	Buy	+5,000	New	+$262K	﹤0.01%	3332

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management's IART Position: Q1 2026 in Review

Millennium Management increased its Integra LifeSciences (IART) stake by 318% in Q1 2026, buying an estimated $5.2M and bringing the position to 622,853 shares worth $5.87M. The position accounts for ﹤0.01% of the portfolio, ranked #2765.

Millennium Management first reported a position in IART in Q3 2013 and has held it in 39 quarters since. The position peaked at $59.3M in Q1 2017. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

Millennium Management held 622,853 shares of Integra LifeSciences worth $5.87M as of Q1 2026.
Millennium Management bought 473,882 Integra LifeSciences shares in Q1 2026, an estimated $5.2M.
Integra LifeSciences made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2765 holding.
Millennium Management first reported a position in Integra LifeSciences in Q3 2013 and has held it in 39 quarters since.
Millennium Management's Integra LifeSciences position peaked at $59.3M in Q1 2017.
201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.